StockDrifts LogoStockDrifts

Johnson & Johnson

Portfolio Manager
Johnson & Johnson
Performance
+18.25% (2026 Q1)
AUM (13F)
$652.36M
# of Holdings
16
Performance Rank
Allocation (Top 20)
99.99%

Johnson & Johnson Holdings Map

Top 16 Johnson & Johnson Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
PTGX
Protagonist Therapeutics Inc.
39.57%2.45M$258.1M
+0.00%(+0)
2025-Q1: 2.45M shares2025-Q2: 2.45M shares2025-Q3: 2.45M shares2025-Q4: 2.45M shares2026-Q1: 2.45M shares
$31.30(+320.51%)
2026-03-31
NBTX
Nanobiotix S.A.
26.61%5.62M$173.6M
+0.00%(+0)
2025-Q1: 5.62M shares2025-Q2: 5.62M shares2025-Q3: 5.62M shares2025-Q4: 5.62M shares2026-Q1: 5.62M shares
$7.83(+390.64%)
2026-03-31
MGTX
MeiraGTx Holdings plc
8.82%6.64M$57.5M
+0.00%(+0)
2025-Q1: 6.64M shares2025-Q2: 6.64M shares2025-Q3: 6.64M shares2025-Q4: 6.64M shares2026-Q1: 6.64M shares
$10.47(+33.01%)
2026-03-31
RAPP
Rapport Therapeutics, Inc.
8.56%1.78M$55.8M
+0.00%(+0)
2025-Q1: 2.50M shares2025-Q2: 2.50M shares2025-Q3: 1.78M shares2025-Q4: 1.78M shares2026-Q1: 1.78M shares
$23.26(+67.54%)
2026-03-31
CVRX
CVRx, Inc.
5.84%4.02M$38.1M
+0.00%(+0)
2025-Q1: 4.10M shares2025-Q2: 4.10M shares2025-Q3: 4.10M shares2025-Q4: 4.02M shares2026-Q1: 4.02M shares
$22.65(-75.27%)
2026-03-31
CTNM
Contineum Therapeutics Inc.
3.96%1.98M$25.8M
+0.00%(+0)
2025-Q1: 1.98M shares2025-Q2: 1.98M shares2025-Q3: 1.98M shares2025-Q4: 1.98M shares2026-Q1: 1.98M shares
$17.61(-14.25%)
2026-03-31
LEGN
Legend Biotech Corporation
2.26%814.6K$14.7M
+0.00%(+0)
2025-Q1: 814.6K shares2025-Q2: 814.6K shares2025-Q3: 814.6K shares2025-Q4: 814.6K shares2026-Q1: 814.6K shares
$45.81(-34.70%)
2026-03-31
XNCR
Xencor, Inc.
1.38%748.1K$9.0M
+0.00%(+0)
2025-Q1: 748.1K shares2025-Q2: 748.1K shares2025-Q3: 748.1K shares2025-Q4: 748.1K shares2026-Q1: 748.1K shares
$36.39(-58.78%)
2026-03-31
PRCT
Procept BioRobotics Corporation
1.37%357.9K$9.0M
+0.00%(+0)
2025-Q1: 357.9K shares2025-Q2: 357.9K shares2025-Q3: 357.9K shares2025-Q4: 357.9K shares2026-Q1: 357.9K shares
$38.15(-44.88%)
2026-03-31
FATE
Fate Therapeutics, Inc.
0.62%3.38M$4.1M
+0.00%(+0)
2025-Q1: 3.38M shares2025-Q2: 3.38M shares2025-Q3: 3.38M shares2025-Q4: 3.38M shares2026-Q1: 3.38M shares
$73.03(-96.00%)
2026-03-31

Unlock alerts, watchlists & AI chat

Sign up free to track Johnson & Johnson, compare funds side by side, and get alerts the moment positions change.

More 13F analyses

View all